查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
致癌基因组检验及简介的全球市场:COVID-19影响分析，癌症类型，用途，各组织类型的洞察，地区展望，竞争策略，各市场区隔预测(～2027年)
市场调查报告书
商品编码
1070393

致癌基因组检验及简介的全球市场:COVID-19影响分析，癌症类型，用途，各组织类型的洞察，地区展望，竞争策略，各市场区隔预测(～2027年)

Genomic Cancer Panel and Profiling Market with COVID-19 Impact Analysis, By Type of Cancer, Application, Tissue Type Insights- Regional Outlook, Competitive Strategies and Segment Forecasts to 2027
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格

全球致癌基因组检验及简介的市场规模在2020年估算为12亿80万美元，在预测期间内预计将以22.7％的年复合成长率扩大。

本报告提供全球致癌基因组检验及简介市场调查，提供市场概要，市场规模和预测，成长要素及阻碍因素，癌症类型·用途·组织类型·各地区的分析，再加上供应商分析等资讯。

目录

第1章 致癌基因组检验及简介市场市场概要

第2章 摘要整理

  • 市场明细
    • 各癌症类型的市场明细
    • 各用途的市场明细
    • 各组织类型的市场明细
    • 各地区的市场明细
  • 竞争考察

第3章 致癌基因组检验及简介的主要市场趋势

  • 推动市场要素
    • 推动市场要素的影响分析
  • 阻碍市场要素
    • 阻碍市场要素的影响分析
  • 市场机会
  • 市场未来趋势

第4章 致癌基因组检验及简介产业的调查

  • 波特的五力分析
  • 行销策略分析
  • 成长预测製图
  • 法律规范分析

第5章 致癌基因组检验及简介市场:COVID-19影响分析

  • COVID-19前的影响分析
  • COVID-19后的影响分析
    • 最佳收益市场区隔
    • 边际成长市场区隔
    • 最大损失市场区隔
    • 边际损失市场区隔

第6章 致癌基因组检验及简介市场形势

  • 市场占有率分析(2019年)
  • 主要创新者分析
  • 各主要製造商的明细资料
    • 现有企业的分析
    • 新兴企业的分析

第7章 致癌基因组检验及简介市场:各癌症类型

  • 概要

第8章 致癌基因组检验及简介市场:各用途

  • 概要

第9章 致癌基因组检验及简介市场:各组织类型

  • 概要

第10章 致癌基因组检验及简介市场:各地区

  • 简介
  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东和非洲

第11章 供应商分析

  • 有竞争力的仪表板
  • 企业简介
    • 10x Genomics, Inc.
    • BioGenex
    • Cynvenio
    • GILUPI Nanomedizin
    • Millipore Sigma
    • Rarecells SAS
    • ARUP Laboratories
    • Asuragen
    • AVIVA Biosciences
    • Baylor Miraca Genetics Laboratories

第12章 分析师全方位展望

第13章 附录

Product Code: ANV799

REPORT HIGHLIGHT

The genomic cancer panel and profiling market is estimated to be worth US$ 1,200.8 million in 2020. Genomic cancer panel and profiling market is expected to expand at a 22.7% CAGR during the forecast period.

Market Introduction

Genomic profiling, also known as genomic characterization, is a technique for discovering all of a person's or a cell type's genes, as well as understanding how those genes interact with one another and with the environment. The growing number of clinical and preclinical research can be attributed to the changing demands of the evolving diagnostic and therapeutic application areas. Genomic profiling is also used to understand the causes of the development of particular diseases or why different people react to the same medicine in different ways. It could also be utilized to aid in the development of innovative methods for diagnosing, treating, and preventing diseases like cancer and also a lead way for personalized medicines.

Market Dynamics

The rise in incidences of cancer diseases, and the rising adoption of gene panels due to the benefits they provide are all driving the growth of the genomic cancer panel and profiling market. In recent years, the market has witnessed a rapid transformation in the diagnosis and treatment of cancer. As Oncologists begin to routinely use the information on the hundreds of genes linked to cancer, the industry is moving out of a specialized niche and into the mainstream. In addition to this, the growth is also driven by the growing demand for precise cancer detection at an early stage. Many organizations and foundations, such as the WHO's Cancer Preventive Program, the Prevent Cancer Foundation, the National Cancer Control Program, are increasing cancer awareness at the national as well as international level, which is expected to further fuel the growth of the genomic cancer panel and profiling market during the forecast period.

Segmentation Analysis

The genomic cancer panel and profiling market are segmented by type of cancer, application, tissue type, regional distribution, and competitive landscape. Based on the type of cancer, breast cancer is expected to witness the fastest growth during the forecast period, The growth is primarily driven by the growing prevalence of breast cancer and the growing demand for gene panels in cancer diagnosis and research for a better understanding of genetic variability of cancer. According to the World Health Organization, around 627,000 women died from breast cancer worldwide in 2018, and the rate of breast cancer is estimated to be greater among women in developed nations than in developing regions. It is estimated that 1 in 28 women develop breast cancer during their lifetime. In India, it is estimated that by 2030, breast cancer will cause more deaths among women than any other disease. Breast and oral cavity cancer accounted for 25.0 percent of cancer cases in women in 2018, according to Cancer Organization India. Furthermore, the Susan G Komen Breast Cancer Foundation, Inc. estimates that more than 41,000 women die from breast cancer every year in the U.S. Moreover, breast cancer is one of the most frequent types of cancer among women in South Africa, according to the South African Journal of Radiology, and it is also one of the major causes of mortality. Genomic cancer panels and profiling are found to be effective for the detection of early-stage luminal breast cancer.

Competitive Landscape

The global genomic cancer panel and profiling market is fairly fragmented with the presence of large numbers of players in the market. Companies in the space are continuously focusing on research and development, partnerships, collaborations, and new product launches and development to strengthen their presence in the global market. Some of the recent developments are:

In March 2020, Illumina launched TruSight Oncology Comprehensive, a single test that can assess multiple tumor genes and biomarkers.

In May 2019, QIAGEN received FDA approval for PIK3CA RGQ PCR Kit for use as a companion diagnostic for identifying breast cancer patients.

Key features of the study:

This proposed research study on Genomic Cancer Panel and Profiling market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2021-2027), considering 2020 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Genomic Cancer Panel and Profiling market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Genomic Cancer Panel and Profiling market.

Impact of COVID-19 on Genomic Cancer Panel and Profiling market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Genomic Cancer Panel and Profiling market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Genomic Cancer Panel and Profiling market, we have also included competitive landscape and key innovator analysis for the Genomic Cancer Panel and Profiling market

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Genomic Cancer Panel and Profiling market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The Genomic Cancer Panel and Profiling market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

Genomic Cancer Panel and Profiling Market Key Players

10x Genomics, Inc.

BioGenex

Cynvenio

GILUPI Nanomedizin

Millipore Sigma

Rarecells SAS

ARUP Laboratories

Asuragen

AVIVA Biosciences

Baylor Miraca Genetics Laboratories

Genomic Cancer Panel and Profiling Market by Type of Cancer

Breast Cancer

Colorectal Cancer

Blood Cancer

Prostate Cancer

Lung Cancer

Other Cancer

Genomic Cancer Panel and Profiling Market by Application

Clinical Testing

Pharmaceutical Testing

Research Testing

Genomic Cancer Panel and Profiling Market by Tissue Type

Solid Tissue Testing

Liquid Tissue Testing

Genomic Cancer Panel and Profiling Market by Region

North America

United States

Canada

Mexico

Europe

Germany

United Kingdom

France

Italy

Spain

Rest of Europe

Asia-Pacific

China

Japan

India

Australia

South Korea

Rest of Asia-Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle-East and Africa

GCC

South Africa

Rest of Middle-East and Africa

TABLE OF CONTENT

1. Genomic Cancer Panel and Profiling Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Type of Cancer
    • 2.1.2. Market Snippet by Application
    • 2.1.3. Market Snippet by Tissue Type
    • 2.1.4. Market Snippet by Region
  • 2.2. Competitive Insights

3. Genomic Cancer Panel and Profiling Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Genomic Cancer Panel and Profiling Industry Study

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genomic Cancer Panel and Profiling Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Genomic Cancer Panel and Profiling Market Landscape

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. Genomic Cancer Panel and Profiling Market - By Type of Cancer

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type of Cancer, 2020 & 2027 (%)
    • 7.1.2. Breast Cancer
    • 7.1.3. Colorectal Cancer
    • 7.1.4. Blood Cancer
    • 7.1.5. Prostate Cancer
    • 7.1.6. Lung Cancer
    • 7.1.7. Other Cancer

8. Genomic Cancer Panel and Profiling Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2020 & 2027 (%)
    • 8.1.2. Clinical Testing
    • 8.1.3. Pharmaceutical Testing
    • 8.1.4. Research Testing

9. Genomic Cancer Panel and Profiling Market - By Tissue Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Tissue Type, 2020 & 2027 (%)
    • 9.1.2. Solid Tissue Testing
    • 9.1.3. Liquid Tissue Testing

10. Genomic Cancer Panel and Profiling Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.1. U.S. Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.2. U.S. Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.3. U.S. Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.2.8. Canada
      • 1.1.1.4. Overview
      • 1.1.1.5. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.1. Canada Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.2. Canada Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.3. Canada Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.3.7. Germany
      • 1.1.1.6. Overview
      • 1.1.1.7. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.8. Germany Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.9. Germany Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.10. Germany Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.3.8. Italy
      • 1.1.1.11. Overview
      • 1.1.1.12. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.13. Italy Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.14. Italy Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.15. Italy Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.3.9. United Kingdom
      • 1.1.1.16. Overview
      • 1.1.1.17. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.18. United Kingdom Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.19. United Kingdom Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.20. United Kingdom Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.3.10. France
      • 1.1.1.21. Overview
      • 1.1.1.22. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.23. France Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.24. France Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.25. France Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.3.11. Rest of Europe
      • 1.1.1.26. Overview
      • 1.1.1.27. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.28. Rest of the Europe Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.29. Rest of the Europe Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.30. Rest of the Europe Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.4.7. India
      • 1.1.1.31. Overview
      • 1.1.1.32. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.33. India Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.34. India Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.35. India Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.4.8. China
      • 1.1.1.36. Overview
      • 1.1.1.37. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.38. China Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.39. China Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.40. China Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.4.9. Japan
      • 1.1.1.41. Overview
      • 1.1.1.42. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.43. Japan Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.44. Japan Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.45. Japan Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.4.10. South Korea
      • 1.1.1.46. Overview
      • 1.1.1.47. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.48. South Korea Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.49. South Korea Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.50. South Korea Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.4.11. Rest of APAC
      • 1.1.1.51. Overview
      • 1.1.1.52. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.53. Rest of APAC Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.54. Rest of APAC Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.55. Rest of APAC Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.5.7. Brazil
      • 1.1.1.56. Overview
      • 1.1.1.57. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.58. Brazil Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.59. Brazil Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.60. Brazil Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.5.8. Mexico
      • 1.1.1.61. Overview
      • 1.1.1.62. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.63. Mexico Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.64. Mexico Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.65. Mexico Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.5.9. Argentina
      • 1.1.1.66. Overview
      • 1.1.1.67. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.68. Argentina Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.69. Argentina Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
      • 1.1.1.70. Rest of LATAM Argentina Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.71. Overview
      • 1.1.1.72. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.73. Rest of LATAM Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.74. Rest of LATAM Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.75. Rest of LATAM Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 1.1.1.76. Overview
      • 1.1.1.77. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.78. Saudi Arabia Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.79. Saudi Arabia Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.80. Saudi Arabia Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 1.1.1.81. Overview
      • 1.1.1.82. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.83. United Arab Emirates Market Size and Forecast, By Type of Cancer, 2016 - 2027 (US$ Million)
      • 1.1.1.84. United Arab Emirates Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.85. United Arab Emirates Market Size and Forecast, By Tissue Type, 2016 - 2027 (US$ Million)

11. Key Vendor Analysis

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. 10x Genomics, Inc.
    • 11.2.2. BioGenex
    • 11.2.3. Cynvenio
    • 11.2.4. GILUPI Nanomedizin
    • 11.2.5. Millipore Sigma
    • 11.2.6. Rarecells SAS
    • 11.2.7. ARUP Laboratories
    • 11.2.8. Asuragen
    • 11.2.9. AVIVA Biosciences
    • 11.2.10. Baylor Miraca Genetics Laboratories

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Genomic Cancer Panel and Profiling market: Type of Cancer Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Type of Cancer
  • TABLE Global Genomic Cancer Panel and Profiling market, by Type of Cancer2016-2027 (USD Million)
  • TABLE Genomic Cancer Panel and Profiling market: Tissue Type Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Tissue Type
  • TABLE Global Genomic Cancer Panel and Profiling market, by Tissue Type 2016-2027 (USD Million)
  • TABLE Genomic Cancer Panel and Profiling market: Application Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Genomic Cancer Panel and Profiling market, by Application 2016-2027 (USD Million)
  • TABLE Genomic Cancer Panel and Profiling market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Genomic Cancer Panel and Profiling market, by Region 2016-2027 (USD Million)
  • TABLE North America Genomic Cancer Panel and Profiling market, by Country, 2016-2027 (USD Million)
  • TABLE North America Genomic Cancer Panel and Profiling market, by Type of Cancer, 2016-2027 (USD Million)
  • TABLE North America Genomic Cancer Panel and Profiling market, by Application, 2016-2027 (USD Million)
  • TABLE North America Genomic Cancer Panel and Profiling market, by Tissue Type, 2016-2027 (USD Million)
  • TABLE Europe Genomic Cancer Panel and Profiling market, by Country, 2016-2027 (USD Million)
  • TABLE Europe Genomic Cancer Panel and Profiling market, by Type of Cancer, 2016-2027 (USD Million)
  • TABLE Europe Genomic Cancer Panel and Profiling market, by Application, 2016-2027 (USD Million)
  • TABLE EuropeGenomic Cancer Panel and Profiling market, by Tissue Type, 2016-2027 (USD Million)
  • TABLE Asia Pacific Genomic Cancer Panel and Profiling market, by Country, 2016-2027 (USD Million)
  • TABLE Asia Pacific Genomic Cancer Panel and Profiling market, by Type of Cancer, 2016-2027 (USD Million)
  • TABLE Asia Pacific Genomic Cancer Panel and Profiling market, by Application, 2016-2027 (USD Million)
  • TABLE Asia Pacific Genomic Cancer Panel and Profiling market, by Tissue Type, 2016-2027 (USD Million)
  • TABLE Latin America Genomic Cancer Panel and Profiling market, by Country, 2016-2027 (USD Million)
  • TABLE Latin America Genomic Cancer Panel and Profiling market, by Type of Cancer, 2016-2027 (USD Million)
  • TABLE Latin America Genomic Cancer Panel and Profiling market, by Application, 2016-2027 (USD Million)
  • TABLE Latin America Genomic Cancer Panel and Profiling market, by Tissue Type, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Genomic Cancer Panel and Profiling market, by Country, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Genomic Cancer Panel and Profiling market, by Type of Cancer, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Genomic Cancer Panel and Profiling market, by Application, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Genomic Cancer Panel and Profiling market, by Tissue Type, 2016-2027 (USD Million)

List of Figures

  • FIGURE Genomic Cancer Panel and Profiling market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Type of Cancer segment market share analysis, 2020 & 2027
  • FIGURE Type of Cancer segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Application segment market share analysis, 2020 & 2027
  • FIGURE Application segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Tissue Type segment market share analysis, 2020 & 2027
  • FIGURE Tissue Type segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America Genomic Cancer Panel and Profiling market share and leading players, 2019
  • FIGURE Europe Genomic Cancer Panel and Profiling market share and leading players, 2019
  • FIGURE Asia Pacific Genomic Cancer Panel and Profiling market share and leading players, 2019
  • FIGURE Latin America Genomic Cancer Panel and Profiling market share and leading players, 2019
  • FIGURE Middle East and Africa Genomic Cancer Panel and Profiling market share and leading players, 2019
  • FIGURE North America market share analysis by country, 2019
  • FIGURE U.S. Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Canada Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Europe Genomic Cancer Panel and Profiling market share analysis by country, 2019
  • FIGURE Germany Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Spain Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Italy Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE UK Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE France Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of the Europe Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Asia Pacific Genomic Cancer Panel and Profiling market share analysis by country, 2019
  • FIGURE India Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE China Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Japan Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE South Korea Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Singapore Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of APAC Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Genomic Cancer Panel and Profiling market share analysis by country, 2019
  • FIGURE Brazil Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Mexico Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Argentina Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of LATAM Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Genomic Cancer Panel and Profiling market share analysis by country, 2019
  • FIGURE Saudi Arabia Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE United Arab Emirates Genomic Cancer Panel and Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)